These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 19124911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
    Nuesch R, Ananworanich J, Sirivichayakul S, Ubolyam S, Siangphoe U, Hill A, Cooper D, Lange J, Phanuphak P, Ruxrungtham K.
    Clin Infect Dis; 2005 Mar 01; 40(5):728-34. PubMed ID: 15714420
    [Abstract] [Full Text] [Related]

  • 5. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
    Nicastri E, Sarmati L, d'Ettorre G, Palmisano L, Parisi SG, Uccella I, Rianda A, Concia E, Vullo V, Vella S, Andreoni M.
    J Med Virol; 2003 Jan 01; 69(1):1-6. PubMed ID: 12436471
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.
    Lohse N, Jørgensen LB, Kronborg G, Møller A, Kvinesdal B, Sørensen HT, Obel N, Gerstoft J, Danish HIV Cohort Study.
    Antivir Ther; 2007 Jan 01; 12(6):909-17. PubMed ID: 17926645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
    Sukasem C, Churdboonchart V, Sukeepaisarncharoen W, Piroj W, Inwisai T, Tiensuwan M, Chantratita W.
    Int J Antimicrob Agents; 2008 Mar 01; 31(3):277-81. PubMed ID: 18182278
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amprenavir in pre-treated patients: virological and immunological response in a cohort of 45 patients.
    Bogner JR, Eberle J, Troendle U, Goebel FD.
    Eur J Med Res; 2003 Feb 21; 8(2):49-55. PubMed ID: 12626281
    [Abstract] [Full Text] [Related]

  • 16. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.
    Indian J Med Microbiol; 2009 Feb 21; 27(3):231-6. PubMed ID: 19584504
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Resistance to anti-retroviral therapy in Chilean patients with HIV-1 from 2002 to 2005].
    Afani S A, Orellana R L, Duarte J P, Acevedo M W, Morales B O, Wolff R M, Vásquez P, Beltrán C.
    Rev Med Chil; 2007 Oct 21; 135(10):1237-44. PubMed ID: 18180829
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.
    Balduin M, Sierra S, Däumer MP, Rockstroh JK, Oette M, Fätkenheuer G, Kupfer B, Beerenwinkel N, Hoffmann D, Selbig J, Pfister HJ, Kaiser R.
    J Clin Virol; 2005 Dec 21; 34(4):277-87. PubMed ID: 16191482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.